Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Hive Digital Technologies Ltd.

Start price
Target price
Perf. (%)
€19.29
15.11.21
€25.00
15.11.22
-12.13%
27.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Bad rating
buy
Sociedad Quimica y Minera de Chile SA ADR

Start price
Target price
Perf. (%)
€58.20
15.11.21
€70.00
15.11.22
-3.78%
27.11.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Valneva SE

Start price
Target price
Perf. (%)
€21.24
15.11.21
€25.00
15.11.22
33.24%
27.11.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
buy
Rio Tinto Ltd

Start price
Target price
Perf. (%)
€59.16
15.11.21
-
15.11.22
1.42%
27.11.21

Could be worthwhile Investment >10% per year
buy
Rio Tinto plc ADR

Start price
Target price
Perf. (%)
€54.50
15.11.21
-
15.11.22
0.92%
27.11.21

Could be worthwhile Investment >10% per year
Nel ASA

Start price
Target price
Perf. (%)
€2.04
15.11.21
€1.00
15.11.22
-35.60%
13.11.22

Revenue growth > 30% per year expected
Small challenges to pay loans and raise capital
Future proof or reliable business model
Higher EBIT margin than peer group
Capsensixx AG

Start price
Target price
Perf. (%)
€15.50
15.11.21
€11.00
15.11.22
0.65%
16.11.22

Probably not worthwhile Investment
overvalued
Outdated or very high risk business model
Very high cyclical dependencies
buy
Artnet AG NA

Start price
Target price
Perf. (%)
€9.70
15.11.21
€9.00
15.11.22
-31.96%
16.11.22

Could be very worthwhile Investment >20% year
Undervalued
Very good company culture
Leading role in innovation
Evofem Biosciences Inc.

Start price
Target price
Perf. (%)
€9.04
14.11.21
€4.50
31.12.23
-21.76%
16.11.21

Could be very worthwhile Investment >20% year
buy
Bolt Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€8.95
14.11.21
€13.00
14.11.22
-85.47%
15.11.22

Could be worthwhile Investment >10% per year
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€210.00
14.11.21
€185.00
14.11.22
-25.98%
15.11.22

EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Higher risks for its business
buy
Nel ASA

Start price
Target price
Perf. (%)
€2.04
14.11.21
€2.10
14.11.22
-33.78%
15.11.22

Innovative
Future proof or reliable business model
Well known brand
No uniques
buy
Ballard Power Systems Inc.

Start price
Target price
Perf. (%)
€16.30
14.11.21
€10.00
14.11.22
-62.67%
15.11.22

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
ROE lower than 10% per year
buy
Encavis AG

Start price
Target price
Perf. (%)
€17.99
14.11.21
€19.70
14.11.22
-9.01%
28.11.21

Differentiated customer and product portfolio
Standard Investments for future growth
High valuation
Higher risks for its business
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€199.52
14.11.21
€230.00
14.11.22
-19.81%
18.03.22

Could be worthwhile Investment >10% per year
Oatly Group Ab

Start price
Target price
Perf. (%)
€10.80
14.11.21
€6.00
14.11.22
-80.56%
15.11.22

Consus Real Estate AG

Start price
Target price
Perf. (%)
€1.51
14.11.21
-
14.11.22
-75.79%
15.11.22

Risky Investment
Exasol AG

Start price
Target price
Perf. (%)
€7.12
14.11.21
-
14.11.22
-55.06%
15.11.22

Risky Investment
Curis Inc.

Start price
Target price
Perf. (%)
€5.06
14.11.21
-
14.11.22
-83.10%
15.11.22

Probably not worthwhile Investment
Can-Fite BioPharma Ltd.

Start price
Target price
Perf. (%)
€11.60
14.11.21
-
14.11.22
-33.62%
15.11.22

Probably not worthwhile Investment
buy
General Cannabis Corp

Start price
Target price
Perf. (%)
€0.35
13.11.21
€2.00
13.11.22
-47.91%
14.11.22

Very Future proof/growth oriented business model
Leading role in innovation
Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
buy
ALK-Abelló A/S B

Start price
Target price
Perf. (%)
€22.33
13.11.21
€24.00
13.11.22
-37.17%
14.11.22

Future proof or reliable business model
Could be worthwhile Investment >10% per year
buy
Hexo Corp.

Start price
Target price
Perf. (%)
€22.26
13.11.21
€28.00
13.11.22
-88.09%
14.11.22

Higher risks for its business
buy
Intershop Communications AG

Start price
Target price
Perf. (%)
€4.68
13.11.21
€5.00
13.11.22
-36.54%
14.11.22

Could be worthwhile Investment >10% per year
Known brand
Top 10 in its market
buy
Repsol S.A.

Start price
Target price
Perf. (%)
€11.03
13.11.21
-
13.11.22
17.64%
15.09.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Capable Management
Future proof or reliable business model